You are here

  • Home
  • Archive
  • Volume 7, Issue 7
  • Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol

Citation Tools

Article menu

Download PDFPDF

XML
Nutrition and metabolism
Protocol
Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Jazayeri-Tehrani SA, Rezayat SM, Mansouri S, et al
Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol
BMJ Open 2017;7:e016914. doi: 10.1136/bmjopen-2017-016914